LOWER RESPIRATORY TRACT DISEASE
Clinical trials for LOWER RESPIRATORY TRACT DISEASE explained in plain language.
Never miss a new study
Get alerted when new LOWER RESPIRATORY TRACT DISEASE trials appear
Sign up with your email to follow new studies for LOWER RESPIRATORY TRACT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Threat vaccine aims to shield seniors from RSV, hMPV, and PIV3
⭐️ VACCINE ⭐️ OngoingThis early-stage study tests a new vaccine called VXB-251 in 240 healthy adults aged 60-83. The vaccine aims to protect against three viruses that cause serious lung infections: RSV, hMPV, and PIV3. Researchers will check if the vaccine is safe and triggers a strong immune respon…
Matched conditions: LOWER RESPIRATORY TRACT DISEASE
Phase: PHASE1 • Sponsor: Vicebio Australia Proprietary Limited • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 05:36 UTC
-
Pregnant RSV shot shields infants: new aussie study
⭐️ VACCINE ⭐️ OngoingThis study looks at how well the RSV vaccine (ABRYSVO) given during pregnancy prevents serious RSV lung infections in babies. Researchers will review health records of infants up to 12 months old who were hospitalized with breathing problems. They will compare RSV test results to…
Matched conditions: LOWER RESPIRATORY TRACT DISEASE
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 05:33 UTC